# Pfizer's Upjohn has merged with Mylan trials: 434 (2026)

ClinicalTrials.gov lists 434 trials with Pfizer's Upjohn has merged with Mylan to form Viatris Inc. as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.: 434 rows for $21.70, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/pfizers-upjohn-has-merged-with-mylan-to-form-viatris-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 434
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 434, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 18, 2020 | NCT04391868 | A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 | Withdrawn | Healthy | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04391868) |
| November 25, 2019 | NCT04176367 | An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under... | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 | Completed | Pharmacokinetics | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04176367) |
| December 7, 2018 | NCT03768726 | Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I... | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Terminated | Bipolar Disorder | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03768726) |
| October 18, 2018 | NCT03711708 | Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03711708) |
| November 17, 2017 | NCT03342690 | Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Observational | Completed | Chronic Heart Failure | 1,165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03342690) |
| November 8, 2016 | NCT02958527 | Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Observational | Completed | Depression/Depressed State | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02958527) |
| August 16, 2016 | NCT02868359 | PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Observational | Completed | Cervical Pain, Neuropathic Pain, Radiating Pain | 369 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02868359) |
| March 31, 2016 | NCT02725112 | Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 | Completed | Healthy | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02725112) |
| January 11, 2016 | NCT02651623 | Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 | Completed | Healthy | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02651623) |
| December 22, 2015 | NCT02637193 | A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 1 | Completed | Healthy Subjects | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02637193) |
| October 1, 2015 | NCT02565615 | Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Observational | Completed | Coronary Artery Disease, Hypercholesterolemia, Hypertension | 5,115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02565615) |
| October 24, 2014 | NCT02273908 | PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Observational | Completed | Low-Back Pain | 331 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02273908) |
| March 3, 2014 | NCT02075047 | Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Terminated | Bipolar Disorder | 171 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02075047) |
| February 27, 2014 | NCT02072824 | A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects \<4 Years of Age With Partial Onset... | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Partial Onset Seizures | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02072824) |
| February 12, 2014 | NCT02060487 | Effects of Oral Sildenafil on Mortality in Adults With PAH | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 | Terminated | Pulmonary Arterial Hypertension | 385 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02060487) |
| November 21, 2013 | NCT01989936 | Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Migraine With or Without Aura | 446 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01989936) |
| November 18, 2013 | NCT01986270 | Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Migraine With or Without Aura | 1,141 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01986270) |
| November 18, 2013 | NCT01986088 | Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Migraine With or Without Aura | 1,008 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01986088) |
| November 7, 2013 | NCT01978496 | Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Migraine With or Without Aura | 1,334 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01978496) |
| October 17, 2013 | NCT01964326 | Actual Use Trial of Atorvastatin Calcium 10 mg | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Hypercholesterolemia | 1,311 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01964326) |
| July 12, 2013 | NCT01897740 | Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Not applicable | No longer available | Pulmonary Arterial Hypertension | Not listed | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01897740) |
| June 27, 2013 | NCT01888497 | Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Healthy | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01888497) |
| May 22, 2013 | NCT01859481 | Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | Completed | Migraine Without Aura, Migraine With Aura | 971 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01859481) |
| April 23, 2013 | NCT01838044 | Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a... | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 | Terminated | Chronic Low Back Pain With a Neuropathic Component | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01838044) |
| March 1, 2013 | NCT01801982 | A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Observational | Completed | Pulmonary Hypertension, Persistent, of the Newborn | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01801982) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 61 |
| Phase 1/2 | 1 |
| Phase 2 | 13 |
| Phase 3 | 144 |
| Phase 4 | 142 |
| Not applicable | 7 |
| Observational | 66 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 377 |
| Terminated | 40 |
| Withdrawn | 13 |
| No longer available | 4 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Schizophrenia | 29 |
| Erectile Dysfunction | 27 |
| Hypertension | 25 |
| Ocular Hypertension | 24 |
| Neuralgia | 22 |
| Epilepsy | 19 |
| Fibromyalgia | 19 |
| Bipolar Disorder | 18 |
| Hypercholesterolemia | 17 |
| Pain | 16 |
| Dyslipidemias | 15 |
| Epilepsies, Partial | 15 |
| Glaucoma, Open-Angle | 15 |
| Glaucoma | 14 |
| Pulmonary Arterial Hypertension | 13 |
| Seizures | 12 |
| Diabetic Neuropathies | 10 |
| Psychotic Disorders | 10 |
| Hypertension, Pulmonary | 10 |
| Sleep Initiation and Maintenance Disorders | 9 |
| Neuralgia, Postherpetic | 8 |
| Hyperlipidemias | 8 |
| Panic Disorder | 7 |
| Cardiovascular Diseases | 6 |
| Urinary Incontinence | 6 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Fire protection companies in the United States](https://specstream.ai/data/businesses/fire-protection-companies/united-states)
- [Forklift dealers in the United States](https://specstream.ai/data/businesses/forklift-dealers/united-states)
- [Generator installation repair companies in the United States](https://specstream.ai/data/businesses/generator-installation-repair-companies/united-states)
- [Guatemalan restaurants in the United States](https://specstream.ai/data/businesses/guatemalan-restaurants/united-states)
- [Home automation companies in the United States](https://specstream.ai/data/businesses/home-automation-companies/united-states)
- [Hostels in the United States](https://specstream.ai/data/businesses/hostels/united-states)
